Holen Sie sich die Stockscreener-App
7.23
4.18%
0.29
Handel nachbörslich:
7.09
-0.14
-1.94%
Schlusskurs vom Vortag:
$6.94
Offen:
$7
24-Stunden-Volumen:
212.92K
Relative Volume:
1.02
Marktkapitalisierung:
$363.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-76.41M
KGV:
-3.7656
EPS:
-1.92
Netto-Cashflow:
$-64.56M
1W Leistung:
+5.70%
1M Leistung:
+12.97%
6M Leistung:
-8.94%
1J Leistung:
-11.29%
1-Tages-Spanne:
$7.00
$7.40
1-Wochen-Bereich:
$6.30
$7.40
52-Wochen-Spanne:
$4.345
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
Firmenname
Aura Biosciences Inc
Sektor
Branche
Telefon
(617)500-8864
Adresse
80 GUEST STREET, BOSTON
Vergleichen Sie AURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
7.23 | 424.11M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-07-19 | Eingeleitet | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Aktie (AURA) Neueste Nachrichten
Aura Biosciences Inc: Promising Clinical Developments and Strong Financial Position Support Buy Rating - TipRanks
Aura Biosciences Inc’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating - TipRanks
Positive Outlook on Aura Biosciences: Strategic Developments and Promising Trials Drive Buy Rating - TipRanks
Aura Biosciences: A Strategic Play in High-Unmet-Need Ocular and Urologic Oncology - AInvest
Order flow analysis tools used on Aura Biosciences Inc.July 2025 Movers & Safe Capital Growth Tips - Newser
What MACD and RSI say about Aura Biosciences Inc.2025 Market Overview & Real-Time Buy Signal Notifications - Newser
Aura Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Is Aura Biosciences Inc. forming a reversal patternEarnings Recap Report & Fast Gaining Stock Reports - Newser
What institutional flow reveals about Aura Biosciences Inc.2025 Institutional Moves & Fast Gaining Stock Strategy Reports - Newser
Aura Biosciences Q2 revenue down 36%, cash to fund ops into H1 2027. - AInvest
Aura Biosciences Reports Q2 Results and $75M Financing - TipRanks
Aura Biosciences : Corporate Presentation August 2025 - MarketScreener
Aura Biosciences Posts Q2 Cash Surge - The Motley Fool
Aura's Vision-Preserving Cancer Therapy Gains Momentum with $75M Boost, Trial Progress - Stock Titan
Aura Biosciences Inc. Trading Near Value Zone — Recovery AheadRisk Controlled Picks With Real Returns Outlined - 선데이타임즈
Market reaction to Aura Biosciences Inc.’s recent newsWeekly Trend Screener with Momentum Picks - Newser
Regression analysis insights on Aura Biosciences Inc. performancePortfolio Building Plan and Summary Guide - Newser
What makes Aura Biosciences Inc. stock price move sharplyPredictive Model for Intraday Swing Forecast - Newser
Combining price and volume data for Aura Biosciences Inc.Portfolio Allocation Strategy for Stability - Newser
Aura Biosciences Inc.’s volatility index tracking explainedMarket Liquidity and Price Flow Analysis - Newser
Key resistance and support levels for Aura Biosciences Inc.Weekly High Conviction Trade Setup Analysis - Newser
Traders Watching For Reversal Pattern in Aura Biosciences Inc.Real-Time Market Sentiment Tracking Gains Momentum - beatles.ru
Can Aura Biosciences Inc. rally from current levelsBuy Signal System Based on Price Action - Newser
Analyzing drawdowns of Aura Biosciences Inc. with statistical toolsFree Access to Real-Time Trade Insights - Newser
Understanding Aura Biosciences Inc.’s price movementSmart Chart Forecasting with AI Algorithms - Newser
Aura Biosciences (AURA) Expected to Announce Quarterly Earnings on Thursday - Defense World
Aura Biosciences Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Why Aura Biosciences Inc. stock attracts strong analyst attentionSmart Trend Analysis With Buy Point Cues - Newser
Aura Biosciences shares fall 1.78% intraday as Wall Street recovers from Friday's selloff. - AInvest
What are Aura Biosciences Inc. company’s key revenue driversFree Trading Psychology Coaching - Jammu Links News
What drives Aura Biosciences Inc. stock priceGet daily expert analysis for smarter investing - Jammu Links News
What analysts say about Aura Biosciences Inc. stockMaximize gains with strategic stock entries - Jammu Links News
What institutional investors are buying Aura Biosciences Inc. stockCapitalize on emerging industry trends - Jammu Links News
Finanzdaten der Aura Biosciences Inc-Aktie (AURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aura Biosciences Inc-Aktie (AURA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Johnson David Michael | Director |
May 16 '25 |
Buy |
4.90 |
20,000 |
98,000 |
166,167 |
| Gibney Anthony S | See Remarks |
May 16 '25 |
Buy |
4.90 |
50,000 |
245,000 |
58,452 |
| Gibney Anthony S | See Remarks |
May 16 '25 |
Sale |
5.15 |
1,519 |
7,823 |
56,933 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):